Effects of High-Resolution Natural Sound with Inaudible High-Frequency Components on Healing, Symptoms, and Sleep Satisfaction in Terminally Ill Cancer Patients

Objectives: This study aimed to assess the effects of high-resolution natural sound with inaudible high-frequency components (HNIH) on healing, symptoms, sleep satisfaction, and autonomic nerve function among terminally ill cancer patients. Methods: We conducted a single-arm, open-label study of 4-h...

全面介紹

書目詳細資料
發表在:Palliative Medicine Reports
Main Authors: Yasutaka Shimotsuura, Keisuke Ishizuka, Takashi Kawaguchi, Kazue Umetsu, Mariko Harada, Yujiro Inoue, Emi Kubo, Kazuhiro Kosugi, Takashi Igarashi, Seiya Enomoto, Hidehiko Taniyama, Tetsuo Iwata, Takuhiro Yamaguchi, Yoshihisa Matsumoto, Tomofumi Miura
格式: Article
語言:英语
出版: Mary Ann Liebert 2025-01-01
主題:
在線閱讀:https://www.liebertpub.com/doi/10.1089/pmr.2024.0089
實物特徵
總結:Objectives: This study aimed to assess the effects of high-resolution natural sound with inaudible high-frequency components (HNIH) on healing, symptoms, sleep satisfaction, and autonomic nerve function among terminally ill cancer patients. Methods: We conducted a single-arm, open-label study of 4-hour HNIH for 20 terminally ill cancer patients. We evaluated the healing state, symptoms (Japanese version of the Edmonton Symptom Assessment System-Revised, ESAS-r-J), global impression, and heart rate variability at 30 minutes (T2) and 4 hours (T3) after starting HNIH and sleep satisfaction the next morning (T4). Results: A total of 18 participants were evaluated (mean age: 69.4 years; 33.3% female). Post-intervention, there was a nonsignificant increase in Healing Scale scores at T2 (mean difference: 5.3, 95% confidence interval [CI]: −1.2 to 11.8, p = 0.106), but a significant increase at T3 (mean difference: 6.6, 95% CI: 1.0 to 12.3, p = 0.024). Specific ESAS-r-J scores demonstrated significant improvements in anxiety (mean difference at T2: −1.2, 95% CI: −1.99 to −0.34, p = 0.008; T3: −1.2, 95% CI: −1.99 to −0.34, p = 0.008), tiredness (mean difference at T2: −0.6, 95% CI: −1.18 to −0.04, p = 0.037), and shortness of breath (mean difference at T2: −1.0, 95% CI: −1.72 to −0.28, p = 0.010). Moreover, 66.7% of participants reported improved general conditions at T2 and T3, whereas 50% reported enhanced sleep satisfaction at T4. Heart rate variability analysis revealed a decreased low-frequency/high-frequency ratio in 55.6% of participants at T2 and 44.4% at T3. Conclusions: The present single-arm study showed that HNIH potentially enhanced healing, alleviated symptoms such as anxiety, tiredness, and shortness of breath, and improved sleep satisfaction in terminally ill cancer patients.
ISSN:2689-2820